Changes for page Customer segments in Health and Wellbeing Living Labs
Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.10
edited by Sarantis Dimitriadis
on 2022/06/07 10:20
on 2022/06/07 10:20
Change comment:
There is no comment for this version
To version 5.5
edited by Sarantis Dimitriadis
on 2022/06/02 10:48
on 2022/06/02 10:48
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -7,8 +7,6 @@ 7 7 (% class="western" lang="en-GB" style="text-align:justify" %) 8 8 (% lang="en-US" %)End users can be classified to non-professional and professional groups. Typical non-professional and professional end-user groups in health and wellbeing includes the following: 9 9 10 -: 11 - 12 12 * ((( 13 13 (% lang="en-US" %)**Non-professional end users:** 14 14 ... ... @@ -17,8 +17,6 @@ 17 17 * (% lang="en-US" %)**Public health and social service clients: **Those who use public services. 18 18 ))) 19 19 20 -: 21 - 22 22 * ((( 23 23 (% lang="en-US" %)**Professional end users** 24 24 ... ... @@ -29,13 +29,9 @@ 29 29 * (% lang="en-US" %)**Policy and decisions makers:** Those responsible for making policies and decisions at local, regional, national or international level. 30 30 ))) 31 31 32 -: 33 - 34 34 (% class="western" lang="en-GB" %) 35 35 (% lang="en-US" %)**Business-to-Business Customer (B2B):** B2B-customer is an organization that purchases living lab services from a living lab. B2B-customers can be classified to private, public, education/ research, civil society organizations and networks/cluster groups as follows: 36 36 37 -: 38 - 39 39 * ((( 40 40 (% lang="en-US" %)**Private sector organizations: **(business developers and researchers) 41 41 ... ... @@ -50,8 +50,6 @@ 50 50 * (% lang="en-US" %)Pharmaceutical companies 51 51 ))) 52 52 53 -: 54 - 55 55 * ((( 56 56 (% lang="en-GB" %) 57 57 (% lang="en-US" %)**Public sector organizations:** ... ... @@ -67,8 +67,6 @@ 67 67 * (% lang="en-US" %)**Public funder:** Government or other European, national, regional or local public institutions who is providing public funding for a specific living lab living lab research project via call for application process. 68 68 ))) 69 69 70 -: 71 - 72 72 * ((( 73 73 (% lang="en-GB" %) 74 74 (% lang="en-US" %)**Education and research organizations:** ... ... @@ -82,8 +82,6 @@ 82 82 * (% lang="en-US" %)**Private research organizations** such as technology and innovation centers 83 83 ))) 84 84 85 -: 86 - 87 87 * ((( 88 88 (% lang="en-GB" %) 89 89 (% lang="en-US" %)**Civil society organizations:** ... ... @@ -91,8 +91,6 @@ 91 91 * (% lang="en-US" %)Non-governmental organizations (NGO) and nonprofit entities operating at international, national, regional or local level. 92 92 ))) 93 93 94 -: 95 - 96 96 * ((( 97 97 (% lang="en-GB" %) 98 98 (% lang="en-US" %)**Networks and clusters:** ... ... @@ -101,189 +101,189 @@ 101 101 * (% lang="en-US" %)International, national, regional and local networks 102 102 ))) 103 103 104 -: 105 - 106 106 (% class="western" lang="en-GB" %) 107 107 (% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table . 108 108 109 -(% style="margin-left:auto; margin-right:auto" %) 110 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; text-align:center; vertical-align:middle; width:634px" %)((( 91 +(% cellspacing="0" style="border-collapse:collapse; margin-left:auto; margin-right:auto" %) 92 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:11px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 111 111 (% class="western" lang="en-GB" style="text-align:center" %) 112 112 (% lang="en-US" %)**Age or age group** 113 113 ))) 114 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 96 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 97 +(% class="western" lang="en-GB" %) 115 115 (% lang="en-US" %)Specific age range 116 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)((( 99 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 100 +(% class="western" %) 117 117 118 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:153px" %)(((102 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 119 119 (% class="western" %) 120 120 121 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:justify; vertical-align:middle; width:152px" %)(((105 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 122 122 (% class="western" %) 123 123 124 124 ))) 125 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:justify; vertical-align:middle; width:153px" %)(((109 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 126 126 (% class="western" lang="en-GB" %) 127 127 (% lang="en-US" %)Elderly 128 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 112 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 129 129 (% class="western" lang="en-GB" %) 130 130 (% lang="en-US" %)Adults 131 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 115 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 132 132 (% class="western" lang="en-GB" %) 133 133 (% lang="en-US" %)Youth 134 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 118 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 135 135 (% class="western" lang="en-GB" %) 136 136 (% lang="en-US" %)Children 137 137 ))) 138 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((122 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 139 139 (% class="western" %) 140 140 141 141 ))) 142 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 30px; text-align:center; vertical-align:middle; width:634px" %)(((126 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 143 143 (% class="western" lang="en-GB" style="text-align:center" %) 144 144 (% lang="en-US" %)**Health status** 145 145 ))) 146 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:justify; vertical-align:middle; width:153px" %)(((130 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 147 147 (% class="western" lang="en-GB" %) 148 148 (% lang="en-US" %)Healthy 149 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 133 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 150 150 (% class="western" lang="en-GB" %) 151 151 (% lang="en-US" %)Patient 152 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:153px" %)((( 136 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:153px" %)((( 153 153 (% class="western" lang="en-GB" %) 154 154 (% lang="en-US" %)Rehabilitant 155 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:justify; vertical-align:middle; width:152px" %)((( 139 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:justify; vertical-align:middle; width:152px" %)((( 156 156 (% class="western" lang="en-GB" %) 157 157 (% lang="en-US" %)Recovered/Survivor 158 158 ))) 159 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((143 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 160 160 (% class="western" %) 161 161 162 162 ))) 163 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 30px; text-align:center; vertical-align:middle; width:634px" %)(((147 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 164 164 (% class="western" lang="en-GB" style="text-align:center" %) 165 165 (% lang="en-US" %)**A specific disease, disorder or disability** 166 166 ))) 167 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 151 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 168 168 (% class="western" lang="en-GB" %) 169 169 (% lang="en-US" %)ADHD 170 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 154 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 171 171 (% class="western" lang="en-GB" %) 172 172 (% lang="en-US" %)Dementia 173 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 157 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 174 174 (% class="western" lang="en-GB" %) 175 175 (% lang="en-US" %)Parkinsons’ disease 176 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 160 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 177 177 (% class="western" lang="en-GB" %) 178 178 (% lang="en-US" %)Loneliness and Social Isolation 179 179 ))) 180 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:left; vertical-align:middle; width:153px" %)(((164 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 181 181 (% class="western" lang="en-GB" %) 182 182 (% lang="en-US" %)Autism 183 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 167 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 184 184 (% class="western" lang="en-GB" %) 185 185 (% lang="en-US" %)Down syndrome 186 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 170 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 187 187 (% class="western" lang="en-GB" %) 188 188 (% lang="en-US" %)Physical disability 189 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 173 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 190 190 (% class="western" lang="en-GB" %) 191 191 (% lang="en-US" %)Mental health 192 192 ))) 193 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 177 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 194 194 (% class="western" lang="en-GB" %) 195 195 (% lang="en-US" %)Cardiovascular disease 196 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 180 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 197 197 (% class="western" lang="en-GB" %) 198 198 (% lang="en-US" %)Idiopathic pulmonary fibrosis (IPF) 199 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 183 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 200 200 (% class="western" lang="en-GB" %) 201 201 (% lang="en-US" %)Sleep apnea/apnea 202 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 186 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 203 203 (% class="western" lang="en-GB" %) 204 204 (% lang="en-US" %)Mild cognitive impairment 205 205 ))) 206 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 190 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 207 207 (% class="western" lang="en-GB" %) 208 208 (% lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD) 209 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 193 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 210 210 (% class="western" lang="en-GB" %) 211 211 (% lang="en-US" %)Language disability 212 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 196 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 213 213 (% class="western" lang="en-GB" %) 214 214 (% lang="en-US" %)Substance abuse (drugs, alcohol) 215 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 199 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 216 216 (% class="western" lang="en-GB" %) 217 217 (% lang="en-US" %)Multiple sclerosis 218 218 ))) 219 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:left; vertical-align:middle; width:153px" %)(((203 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 220 220 (% class="western" lang="en-GB" %) 221 221 (% lang="en-US" %)Cognitive disorder (mild, major) 222 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 206 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 223 223 (% class="western" lang="en-GB" %) 224 224 (% lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation 225 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 209 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 226 226 (% class="western" lang="en-GB" %) 227 227 (% lang="en-US" %)Trauma patient 228 228 229 229 (% class="western" lang="en-GB" %) 230 230 (% lang="en-US" %)(e.g., a spinal cord injury) 231 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 215 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 232 232 (% class="western" lang="en-GB" %) 233 233 (% lang="en-US" %)Neurodegenerative diseases 234 234 ))) 235 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((219 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 236 236 (% class="western" %) 237 237 238 238 ))) 239 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 30px; text-align:center; vertical-align:middle; width:634px" %)(((223 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 240 240 (% class="western" lang="en-GB" style="text-align:center" %) 241 241 (% lang="en-US" %)**Clients of a specific service** 242 242 ))) 243 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:left; vertical-align:middle; width:153px" %)(((227 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:11px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 244 244 (% class="western" lang="en-GB" %) 245 245 (% lang="en-US" %)Child welfare 246 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 230 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 247 247 (% class="western" lang="en-GB" %) 248 248 (% lang="en-US" %)Nursing home 249 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 233 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 250 250 (% class="western" lang="en-GB" %) 251 251 (% lang="en-US" %)Employment service 252 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 236 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 253 253 (% class="western" %) 254 254 255 255 ))) 256 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:left; vertical-align:middle; width:153px" %)(((240 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 257 257 (% class="western" lang="en-GB" %) 258 258 (% lang="en-US" %)Early childhood education 259 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 243 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 260 260 (% class="western" lang="en-GB" %) 261 261 (% lang="en-US" %)Home care 262 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 246 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 263 263 (% class="western" lang="en-GB" %) 264 264 265 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 249 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 266 266 (% class="western" lang="en-GB" %) 267 267 268 268 ))) 269 -|(% colspan="4" style="border- color:currentcolor; border-style:none; border-width:medium; height:30px; vertical-align:top; width:634px" %)(((253 +|(% colspan="4" style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:12px; padding:0in; vertical-align:top; width:634px" %)((( 270 270 (% class="western" %) 271 271 272 272 ))) 273 -|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height: 30px; text-align:center; vertical-align:middle; width:634px" %)(((257 +|(% colspan="4" style="border-color:#000000 currentcolor; border-style:solid none; border-width:1px medium; height:12px; padding:0.04in 0in; text-align:center; vertical-align:middle; width:634px" %)((( 274 274 (% class="western" lang="en-GB" style="text-align:center" %) 275 275 (% lang="en-US" %)**Vulnerable groups** 276 276 ))) 277 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height: 30px; text-align:left; vertical-align:middle; width:153px" %)(((261 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:50px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 278 278 (% class="western" lang="en-GB" %) 279 279 (% lang="en-US" %)Minors/Children 280 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 264 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 281 281 (% class="western" lang="en-GB" %) 282 282 (% lang="en-US" %)Single parents with minor children 283 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 267 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 284 284 (% class="western" lang="en-GB" %) 285 285 (% lang="en-US" %)Persons subjected to psychological, physical or sexual violence 286 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 270 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 287 287 (% class="western" lang="en-GB" %) 288 288 (% lang="en-US" %)Substance users 289 289 ... ... @@ -290,51 +290,51 @@ 290 290 (% class="western" lang="en-GB" %) 291 291 (% lang="en-US" %)(drugs, alcohol) 292 292 ))) 293 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align:left; vertical-align:middle; width:153px" %)((( 277 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 294 294 (% class="western" lang="en-GB" %) 295 295 (% lang="en-US" %)Disabled people 296 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 280 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 297 297 (% class="western" lang="en-GB" %) 298 298 (% lang="en-US" %)Victims of trafficking in human beings 299 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 283 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 300 300 (% class="western" lang="en-GB" %) 301 301 (% lang="en-US" %)Ethnic minorities and immigrants 302 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 286 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 303 303 (% class="western" lang="en-GB" %) 304 304 (% lang="en-US" %)Isolated people 305 305 ))) 306 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; text-align: justify; vertical-align:middle; width:153px" %)(((290 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:30px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 307 307 (% class="western" lang="en-GB" %) 308 308 (% lang="en-US" %)Elderly people 309 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 293 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 310 310 (% class="western" lang="en-GB" %) 311 311 (% lang="en-US" %)Persons with serious illnesses 312 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 296 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 313 313 (% class="western" lang="en-GB" %) 314 314 (% lang="en-US" %)Homeless people 315 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 299 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 316 316 (% class="western" lang="en-GB" %) 317 317 (% lang="en-US" %)Ex-prisoners and people with criminal background 318 318 ))) 319 -|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; text-align:left; vertical-align:middle; width:153px" %)((( 303 +|(% style="border-color:currentcolor; border-style:none; border-width:medium; height:12px; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 320 320 (% class="western" lang="en-GB" %) 321 321 (% lang="en-US" %)Pregnant women 322 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 306 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 323 323 (% class="western" lang="en-GB" %) 324 324 (% lang="en-US" %)Persons with mental disorders 325 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:153px" %)((( 309 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:153px" %)((( 326 326 (% class="western" lang="en-GB" %) 327 327 328 -)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; text-align:left; vertical-align:middle; width:152px" %)((( 312 +)))|(% style="border-color:currentcolor; border-style:none; border-width:medium; padding:0in; text-align:left; vertical-align:middle; width:152px" %)((( 329 329 (% class="western" lang="en-GB" %) 330 330 331 331 ))) 332 332 333 -: 334 334 335 335 (% class="western" lang="en-GB" %) 336 336 (% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table . 337 337 321 + 338 338 |**Researcher expertise**|**Brief use case description** 339 339 |Policy Makers|Studying the impact of new service models or new collaboration models in healthcare, designing or improving policies, gathering requirements for improving health and wellbeing of citizens, co-creation of research methodologies for policy making 340 340 |Experts in communication studies|Defining written, oral, visual and digital communication within a certain workplace. Evaluating (multi professional) healthcare team collaboration, communication and debriefing in various healthcare situations in simulated environments (especially in Simulation lab)